MPG.eBooks - Search Results

1

Entyvio (Vedolizumab)

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Crohn Disease / drug therapy...”

Read Now

2

TNFα-inhibitors in inflammatory bowel disease

by Ringerike, Tove
Published 2008

Norwegian Knowledge Centre for the Health Services

Subjects: “...Tumor Necrosis Factor-alpha / drug effects...”

Read Now

3

CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Arthritis, Rheumatoid / drug therapy...”

Read Now

4

CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Arthritis, Rheumatoid / drug therapy...”

Read Now

5

CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis

Published 2018

CADTH

Subjects: “...Drug Costs...”

Read Now

6

CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Costs...”

Read Now

7

CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Costs...”

Read Now

8

The use of human growth hormone for children with idiopathic short stature

Published 2000

Minnesota Dept. of Health

Subjects: “...Growth Disorders / drug therapy...”

Read Now

9

Reslizumab (Cinqair)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Asthma / drug therapy...”

Read Now

10

Somatropin (Genotropin) for subcutaneous injection : the treatment of short stature associated with Turner syndrome in patients whose epiphyses are not closed

Published 2014

CADTH

Subjects: “...Turner Syndrome / drug therapy...”

Read Now

11

Clinical review report: Brolucizumab (Beovu) (Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular degeneration (AMD)

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Wet Macular Degeneration / drug therapy...”

Read Now

12

Immune checkpoint inhibitors for classical Hodgkin lymphoma in brentuximab vedotin-naïve patients : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Williams, D., Gray, Casey, Picheca, Lory
Published 2019

CADTH

Subjects: “...Hodgkin Disease / drug therapy...”

Read Now

13

Effectiveness of recombinant human growth hormone (rhGH) in the treatment of patients with cystic fibrosis

by Phung, Olivia J.
Published 2010

Agency for Healthcare Research and Quality

Subjects: “...Cystic Fibrosis / drug therapy...”

Read Now

14

Somatropin (Genotropin) for subcutaneous injection : long-term treatment of children who have growth failure due to an inadequate secretion of endogenous growth hormone

Published 2014

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Dwarfism, Pituitary / drug therapy...”

Read Now

15

Clinical review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Arthritis, Psoriatic / drug therapy...”

Read Now

16

Pharmacoeconomic review report: Burosumab (Crysvita), Kyowa Kirin Limited : indication : for the treatment of x-linked hypophosphatemia in adult and pediatric patients one year of...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Familial Hypophosphatemic Rickets / drug therapy...”

Read Now

17

Effectiveness of recombinant human growth hormone (rhGH) in the treatment of patients with cystic fibrosis

by Phung, Olivia J.
Published 2010

Agency for Healthcare Research and Quality

Subjects: “...Cystic Fibrosis / drug therapy...”

Read Now

18

Tocilizumab (Actemra) : adult patients with moderately to severely active rheumatoid arthritis

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Arthritis, Rheumatoid / drug therapy...”

Read Now

19

Clinical review report: Burosumab (Crysvita) (Kyowa Kirin limited) : indication: for the treatment of x-linked hypophosphatemia in adult and pediatric patients one year of age and...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Familial Hypophosphatemic Rickets / drug therapy...”

Read Now

20

Clinical review report: Tocilizumab (Actemra) (Hoffmann-La Roche Limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Giant Cell Arteritis / drug therapy...”

Narrow Search